Hi Tiger 3152
There are those that suggest that M&G will not be in that first Troponin test.
Nobody outside of Philips knows the answer
But , there has never been any indication from the company that it IS or IS NOT included.
And Anteo/GC has said that work for POC1 was going wel/ahead of scedule
Does it suit some agenda's to keep the pessimism alive until the announcement?
I do not believe that Philips would start with a under-performing test as the market for diagnostics is getting increasingly competitive
E.G
RB
[/table]
Column 1 0
Column 1 0 Lower sales of Sanofi's longtime best-seller Lantus--in the U.S. because of higher-than-expected rebates, in Europe because of biosimilar competition--dragged the company's diabetes franchise down by 6.6%
POC and troponin first release, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.84M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.0¢ | $82.21K | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1315249 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 250000 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| ADO (ASX) Chart |